CJC/Ipamorelin

CJC/Ipamorelin is a two-peptide research combination commonly used to study pulsatile growth-hormone axis signaling by pairing a GHRH-pathway analog (CJC) with a ghrelin-receptor agonist (Ipamorelin).

• What it is: Combination of CJC-1295 (GHRH analog) + Ipamorelin (GHS-R/ghrelin receptor agonist).

• Primary research use: Investigating GH/IGF-1 axis dynamics, including secretion amplitude, pulsatility, and downstream signaling biomarkers.

• Common research context: Endocrine/metabolic and recovery-related preclinical models where dual-pathway GH secretagogue signaling is being evaluated.

For research use only. Not for human or veterinary use. Not for therapeutic or diagnostic use.

COA provided by the Goodlife Group